We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$893B
AUM Growth
+$25.3B
Cap. Flow
+$70.6B
Cap. Flow %
7.9%
Top 10 Hldgs %
27.25%
Holding
14,567
New
2,388
Increased
5,757
Reduced
4,870
Closed
1,500

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$2.65B
2
TSM icon
TSMC
TSM
+$1.25B
3
MSFT icon
Microsoft
MSFT
+$1.1B
4
MU icon
Micron Technology
MU
+$957M
5
UNH icon
UnitedHealth
UNH
+$774M

Sector Composition

Rank Sector Weight
1 Technology 2.02%
2 Consumer Discretionary 0.76%
3 Healthcare 0.56%
4 Financials 0.54%
5 Communication Services 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHM icon
13126
CALL
Autohome
ATHM
$2.5B
-36,100
Closed -$804K
ATLC icon
13127
Atlanticus Holdings
ATLC
$1.43B
-3,427
Closed -$229K
ATLO icon
13128
CALL
AMES National
ATLO
$282M
-12,600
Closed -$289K
ATMCW
13129
DELISTED
AlphaTime Acquisition Corp Warrant
ATMCW
-13,485
Closed -$945
ATNM icon
13130
CALL
Actinium Pharmaceuticals
ATNM
$33.9M
-13,100
Closed -$17.8K
ATOS icon
13131
Atossa Therapeutics
ATOS
$26.7M
-38,839
Closed -$246K
ATRA icon
13132
Atara Biotherapeutics
ATRA
$98.8M
-14,018
Closed -$254K
ATXG icon
13133
Addentax Group
ATXG
$4.35M
-2,008
Closed -$11.8K
ATXS
13134
DELISTED
Astria Therapeutics
ATXS
-36,322
Closed -$475K
ATXS
13135
PUT
DELISTED
Astria Therapeutics
ATXS
-19,600
Closed -$257K
AUID icon
13136
authID Inc
AUID
$7.86M
-47,586
Closed -$41.6K
AUST icon
13137
Austin Gold Corp
AUST
$18.5M
-30,978
Closed -$45.8K
AUTL
13138
PUT
Autolus Therapeutics
AUTL
$649M
-10,000
Closed -$19.9K
AVAH icon
13139
CALL
Aveanna Healthcare
AVAH
$2.97B
-40,300
Closed -$329K
AVDL
13140
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-1,714,600
Closed -$36.9M
AVDL
13141
DELISTED
Avadel Pharmaceuticals
AVDL
-61,690
Closed -$1.33M
AVDL
13142
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
-238,800
Closed -$5.15M
AVEM icon
13143
Avantis Emerging Markets Equity ETF
AVEM
$28B
-161,480
Closed -$12.4M
AVNV icon
13144
Avantis All International Markets Value ETF
AVNV
$70.1M
-3,640
Closed -$272K
AVTX icon
13145
Avalo Therapeutics
AVTX
$1.06B
-210,994
Closed -$3.3M
AWP
13146
abrdn Global Premier Properties Fund
AWP
$363M
-5,427
Closed -$62.5K
AWR icon
13147
PUT
American States Water
AWR
$3.58B
-2,900
Closed -$210K
AXGN icon
13148
PUT
Axogen
AXGN
$2.68B
-11,900
Closed -$389K
AXTA icon
13149
Axalta
AXTA
$7.79B
-102,707
Closed -$3.26M
BALY icon
13150
Bally's
BALY
$479M
-13,638
Closed -$225K

Similar funds

Jeff Yass's Q1 2026 Portfolio in Review

As of Q1 2026, Jeff Yass held 14,567 positions worth $893B, up 2.9% from $868B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $70.6B of net new capital in Q1 2026, opening 2,388 new positions and adding to 5,757 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 830,625 shares worth $54.1M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.7% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was JPMorgan International Research Enhanced Equity ETF, an estimated $785M trimmed.

  • Jeff Yass's largest Q1 2026 buy was Sunbelt Rentals Holdings: 830,625 shares worth $54.1M.
  • Jeff Yass added most to Invesco QQQ Trust in Q1 2026, an estimated $2.65B increase.
  • Jeff Yass's biggest Q1 2026 reduction was JPMorgan International Research Enhanced Equity ETF, cutting an estimated $785M.
  • Jeff Yass fully exited Schwab International Equity ETF in Q1 2026, selling an estimated $147M.
  • Jeff Yass's ten largest holdings make up 27% of its $893B portfolio in Q1 2026.
  • Jeff Yass opened 2,388 new positions and closed 1,500 in Q1 2026.
  • Jeff Yass's portfolio value rose 2.9% quarter-over-quarter to $893B.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.